Antepartum Monitoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Antepartum Monitoring Device Market By Products Type (Ultrasound Devices And Fetal Doppler Devices), Method (Non-Invasive And Invasive), Mobility (Portable And Non Portable), End-User (Hospitals, Obstetrics & Gynecology Clinics, And Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalance of complications associated with pregnancy, rising awareness and focus on fetal monitoring, and increasing number of product launches across the globe.

The global antepartum monitoring device market is estimated to grow at a CAGR of 5.81% during the forecast period from 2024 to 2030. The demand for antepartum monitoring devices is experiencing a significant boost due to the increasing prevalence of complications in pregnancy such as multiple gestations, preterm labor, gestational diabetes, and fetal anomalies. Additionally, heightened awareness about the critical importance of regular fetal monitoring and introduction of numerous technologically advanced products in the market are some of the factors fueling the expansion of the antepartum monitoring device market during the forecast period from 2024 to 2030.

Antepartum Monitoring Device Market Dynamics:

According to the latest data provided by the World Health Organization (WHO) (2023), in 2020 it was estimated that around 13.4 million premature babies were born globally. Antepartum monitoring devices play a pivotal role in managing pregnancies at risk of preterm birth, which occurs when a baby is born before 37 weeks of gestation. Thus, the increasing prevalence of preterm birth will, thereby boost the market of antepartum monitoring devices.

Furthermore, as per the latest data provided by the International Diabetes Federation (IDF), in 2021 gestational diabetes rates varied globally, with approximately 13% reported in Africa, 15% in Europe, 12.8% in Australia, 8.8% in France, 29.3% in India, 32.8% in Spain, and 20.6% in the United Kingdom. Gestational diabetes poses significant risks to both maternal and fetal health, including complications such as macrosomia (excessive birth weight), fetal distress, preterm birth, and increased likelihood of cesarean delivery. To address these risks, antepartum monitoring devices play a crucial role in assessing fetal well-being, monitoring fetal growth, and detecting signs of distress or compromise in pregnancies affected by gestational diabetes. Thus, the increasing prevalence of complications during the pregnancy, will eventually propel the growth of the antepartum monitoring devices during the forecast period.

Further, increasing number of product launches across the globe will also help in driving the market for antepartum monitoring devices. For instance, in December 2023, Siemens Healthineers introduced the Acuson Maple ultrasound system, a state-of-the-art device powered by artificial intelligence (AI). This innovative system incorporates an 'Auto OB feature,' leveraging AI algorithms to accurately calculate fetal age and weight. Notably, this feature contributes to a remarkable 24 percent reduction in the time required to perform fetal measurements during ultrasound examinations. This advancement represents a significant improvement in efficiency and accuracy in fetal and prenatal care, enhancing the overall experience for both healthcare providers and expectant mothers thereby boosting the overall market of antepartum monitoring devices.

However, the risk of infection and discomfort during the placement of invasive monitoring devices and technical inaccuracies due to incorrect placement of the monitoring devices, maternal movement, and signal interference may hinder the growth of antepartum monitoring devices.

Antepartum Monitoring Device Segment Analysis:

Antepartum monitoring device market by Product type (Ultrasound Devices and Fetal Doppler Devices), Method (Non-invasive and Invasive), Mobility (Portable and Non Portable), End-User (Hospitals, Obstetrics & Gynecology Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the antepartum monitoring device market, the ultrasound devices category is estimated to mass a significant revenue share in the antepartum monitoring device market in 2023. This can be attributed to the various advantages and applications provided by the ultrasound devices. Ultrasound fetal devices are non-invasive, which makes them safer and more comfortable for expectant mothers compared to invasive monitoring methods such as fetal scalp electrodes. Additionally, ultrasound fetal devices provide real-time imaging of the fetus, allowing healthcare providers to visualize fetal anatomy, movement, and position. Further, advancement in technology, such as 3D/4D ultrasound imaging, color Doppler imaging, and artificial intelligence (AI)-based algorithms, has further enhanced the capabilities of ultrasound fetal devices, improving diagnostic accuracy and clinical decision-making.

Furthermore, as the demand for this segment grows, various novel products are being launched by market players. For instance, in November 2023 Intelligent Ultrasound introduced ScanNav FetalCheck scanning technology. The technology is specially designed to empower both skilled and non-skilled users to accurately determine gestational age (GA) with minimal training.

Therefore, owing to the above-mentioned factors, the ultrasound devices category is expected to register significant growth, thereby driving the growth of the antepartum monitoring devices market during the forecast period.

North America Is Expected To Dominate The Overall Antepartum Monitoring Device Market:

North America is expected to account for the highest proportion of the antepartum monitoring device market in 2023, out of all regions. This is due to the increasing cases of complications associated with the pregnancy, increasing incidence of premature birth, increasing awareness for fetal and parental monitoring, and increasing launch of technologically advanced products across the region.

According to, to the data provided by the Centers for Disease Control and Prevention (CDC) (2024), in 2022, the birth rate was 11 per 1000 people and the fertility rate was 56.3 births per 1000 women aged between 15- 44 in the United States. Higher birth and fertility rates lead to an increased number of pregnancies, resulting in greater demand for prenatal care, resulting in increasing adoption of the antepartum monitoring devices. As a result, the timely use of antepartum monitoring devices can help to reduce the risk of pre-birth mortality rate as pregnancies at risk of preterm birth require more frequent and intensive monitoring to assess fetal well-being thereby boosting the market of antepartum monitoring devices.

Further, various key product launches and product approvals in the region are some of the other factors that are influencing the positive growth of the antepartum monitoring devices market in North America. For instance, in July 2022, GE Healthcare introduced Voluson™ Expert 22, an advanced ultra-premium ultrasound for Women’s Health, featuring AI-powered tools like SonoLyst, SonoPelvicFloor, and SonoCNS. These tools enhance efficiency by up to 65%, 80%, and 81% respectively, by automating annotations, measurements, plane alignment, and workflow guidance, ultimately improving exam accuracy and reducing uncertainty.

Therefore, the factors mentioned above, and the increasing product launches in the region are some of the important factors which are thereby responsible for driving the overall market for antepartum monitoring devices in North America during the forecast period.

Antepartum Monitoring Device Market Key Players:

Some of the key market players operating in the antepartum monitoring device include CooperSurgical, Inc., Huntleigh Healthcare Limited., GE HealthCare., Bistos Co., Ltd., EDAN Diagnostics, Inc., Koninklijke Philips N.V., Siemens Healthineers AG, BD, Abbott., FUJIFILM SonoSite, Inc., Spacelabs Healthcare, Nihon Kohden Corporation, Nonin Medical, Inc., Medtronic, Natus Medical Incorporated, Neoventa Medical, Nihon Kohden Corporation, Hill-Rom Holdings, Inc., Cardinal Health, Arjo, and others.

Recent Developmental Activities In The Antepartum Monitoring Device Market:

• In January 2024, Samsung announced acquisition of Sonio, a fetal ultrasound AI software company, in a move aimed at bolstering its prominent position in the realm of cutting-edge medical devices. This acquisition is particularly focused on enhancing Samsung's offerings in obstetrics and gynecology ultrasound, with a specific emphasis on incorporating AI assistant features.
• In October 2023, Philips introduces new advancements in OB/GYN ultrasound at ISUOG 2023 to improve early detection and boost diagnostic confidence.
• In June 2020, Philips introduced a new wireless Avalon CL Fetal and Maternal Pod and Patch. It enables continuous, non-invasive monitoring of maternal heart rate, fetal heart rate, and uterine activity using a single disposable device.

Key Takeaways From The Antepartum Monitoring Device Market Report Study

• Market size analysis for current antepartum monitoring device market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global antepartum monitoring device market.
• Various opportunities available for the other competitors in the Antepartum Monitoring Device Market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current Antepartum Monitoring Device market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Antepartum Monitoring Device market growth in the coming future?

Target Audience Who Can Be Benefited From This Antepartum Monitoring Device Market Report Study

• Antepartum Monitoring Device product providers
• Research organizations and consulting companies
• Antepartum Monitoring Devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Antepartum Monitoring Device
• Various end-users who want to know more about the Antepartum Monitoring Device Market and the latest technological developments in the Antepartum Monitoring Device Market.

Frequently Asked Questions For The Antepartum Monitoring Device Market:

1. What are antepartum monitoring device?

These are medical devices are used to monitor the health and well-being of the fetus during pregnancy, before the onset of labor. Besides, this these monitors are designed to assess various parameters such as fetal heart rate, uterine activity, and maternal vital signs.

2. What is the market for antepartum monitoring device?

The global antepartum monitoring device market is estimated to grow at a CAGR of 5.81% during the forecast period from 2024 to 2030.

3. What are the drivers for the global antepartum monitoring device market?

The demand for antepartum monitoring devices is experiencing a significant boost due to the increasing incidence of complications in pregnancy such as multiple gestations, preterm labor, gestational diabetes, and fetal anomalies. Additionally, heightened awareness about the critical importance of regular fetal monitoring and introduction of numerous technologically advanced products in the market are some of the factors fueling the expansion of the antepartum monitoring device market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the global antepartum monitoring device market?

Some of the key market players operating in the Antepartum Monitoring Device include CooperSurgical, Inc., Huntleigh Healthcare Limited., GE HealthCare., Bistos Co., Ltd., EDAN Diagnostics, Inc., Koninklijke Philips N.V., Siemens Healthineers AG, BD, Abbott., FUJIFILM SonoSite, Inc., Spacelabs Healthcare, Nihon Kohden Corporation, Nonin Medical, Inc., Medtronic, Natus Medical Incorporated, Neoventa Medical, Nihon Kohden Corporation, Hill-Rom Holdings, Inc., Cardinal Health, Arjo, and others.

5. Which region has the highest share in the global antepartum monitoring device market?

North America is expected to account for the highest proportion of the antepartum monitoring device market in 2023, out of all regions. This is due to the increasing cases of complications associated with the pregnancy, increasing incidence of premature birth, increasing awareness for fetal and parental monitoring, and increase number of product launches with advancements in technology across the region.


This product will be delivered within 2 business days.